Alterations in EGFR and PDGFRA are associated with the localization of contrast-enhancing lesions in glioblastoma.
Makino R, Higa N, Akahane T, Yonezawa H, Uchida H, Takajo T, Fujio S, Kirishima M, Hamada T, Yamahata H, Kamimura K, Yoshiura T, Yoshimoto K, Tanimoto A, Hanaya R.
Makino R, et al. Among authors: hanaya r.
Neurooncol Adv. 2023 Sep 2;5(1):vdad110. doi: 10.1093/noajnl/vdad110. eCollection 2023 Jan-Dec.
Neurooncol Adv. 2023.
PMID: 37744696
Free PMC article.